IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

March Altus Capital Management LP

Q3 2015 Holdings

Filed 2015-11-16 | 14 holdings | $1.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$1.6M48,82599.1%
Edwards Lifesciences Corp(EW)COM28176E108$4.8K34,0690.3%
Gilead Sciences Inc(GILD)COM375558103$1.7K17,1620.1%
Lilly ELI & Co(LLY)COM532457108$1.4K16,8440.1%
Aratana Therapeutics Inc(PETXEUR)COM03874P101$935110,5370.1%
Dexcom Inc(DXCM)COM252131107$8419,7940.1%
Medicines CoCOM584688105$83822,0770.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$8171,7560.1%
Mallinckrodt PUB LTD CoSHSG5785G107$81612,7690.1%
Incyte Corp(INCY)COM45337C102$8107,3440.0%
Medivation IncCOM58501N101$79918,7940.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$69217,3860.0%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$54930,9620.0%
United Therapeutics Corp del(UTHR)COM91307C102$3282,5000.0%